Defence Therapeutics Inc. (DTC) — Financial Flexibility Index
Defence Therapeutics Inc. (DTC) has a Financial Flexibility Index of -0.54x as of December 2025. Free cash flow of €-1.40 Million (operating CF €-1.40 Million minus capex €0.00) represents -1% of total liabilities (€2.59 Million). Also explore net asset growth rate of Defence Therapeutics Inc. to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Defence Therapeutics Inc. Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Defence Therapeutics Inc. across 5 annual periods. See DTC equity financing ratio to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Defence Therapeutics Inc. (2020–2024)
Year-by-year free cash flow to debt coverage for Defence Therapeutics Inc.. For the full company profile including market capitalisation, see Defence Therapeutics Inc. (DTC) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.01x | €-4.09 Million | €-4.29 Million | €4.06 Million | ▲ +73.9% |
| 2023 | -3.86x | €-7.59 Million | €-7.66 Million | €1.97 Million | ▲ +29.3% |
| 2022 | -5.46x | €-6.04 Million | €-6.04 Million | €1.11 Million | ▲ +70.9% |
| 2021 | -18.73x | €-2.29 Million | €-2.29 Million | €122.26K | ▼ -943.1% |
| 2020 | -1.80x | €-86.81K | €-132.83K | €48.35K | — |